CN Patent
CN112261942A — 治疗重度月经出血的方法
Assigned to AbbVie Inc · Expires 2021-01-22 · 5y expired
What this patent protects
本发明涉及一种在患有或未患有子宫肌瘤并需要治疗的受试者中治疗重度月经出血的方法，所述方法通过施用有效量的4‑((R)‑2‑[5‑(2‑氟‑3‑甲氧基‑苯基)‑3‑(2‑氟‑6‑三氟甲基‑苯甲基)‑4‑甲基‑2，6‑二氧代‑3，6‑二氢‑2H‑嘧啶‑1‑基]‑l‑苯基‑乙基氨基)‑丁酸或其药学上可接受的盐与雌激素和孕激素的组合来治疗。
USPTO Abstract
本发明涉及一种在患有或未患有子宫肌瘤并需要治疗的受试者中治疗重度月经出血的方法，所述方法通过施用有效量的4‑((R)‑2‑[5‑(2‑氟‑3‑甲氧基‑苯基)‑3‑(2‑氟‑6‑三氟甲基‑苯甲基)‑4‑甲基‑2，6‑二氧代‑3，6‑二氢‑2H‑嘧啶‑1‑基]‑l‑苯基‑乙基氨基)‑丁酸或其药学上可接受的盐与雌激素和孕激素的组合来治疗。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.